BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16293194)

  • 1. Review of the twelfth West Coast Retrovirus Meeting.
    Barry SM; Melar M; Gallay P; Hope TJ
    Retrovirology; 2005 Nov; 2():72. PubMed ID: 16293194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Functional roles of HIV-1 accessory genes for its pathogenicity].
    Adachi A; Kamada K; Hatcho K; Yamashita T; Uchiyama T; Nomaguchi M
    Tanpakushitsu Kakusan Koso; 2007 Aug; 52(10 Suppl):1261-7. PubMed ID: 17824250
    [No Abstract]   [Full Text] [Related]  

  • 3. Recent advances in the understanding of HIV accessory protein function.
    Steffens CM; Hope TJ
    AIDS; 2001; 15 Suppl 5():S21-6. PubMed ID: 11816170
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV accessory proteins: multifunctional components of a complex system.
    Bour S; Strebel K
    Adv Pharmacol; 2000; 48():75-120. PubMed ID: 10987089
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular biology of the human immunodeficiency virus accessory proteins.
    Subbramanian RA; Cohen EA
    J Virol; 1994 Nov; 68(11):6831-5. PubMed ID: 7933064
    [No Abstract]   [Full Text] [Related]  

  • 6. Vpr and Vpu are important for efficient human immunodeficiency virus type 1 replication and CD4+ T-cell depletion in human lymphoid tissue ex vivo.
    Rücker E; Grivel JC; Münch J; Kirchhoff F; Margolis L
    J Virol; 2004 Nov; 78(22):12689-93. PubMed ID: 15507658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of human immunodeficiency virus type 1 envelope glycoprotein YXXL endocytosis/polarization signal on viral accessory protein functions.
    Cervantes-Acosta G; Lodge R; Lemay G; Cohen EA
    J Hum Virol; 2001; 4(5):249-59. PubMed ID: 11907382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV accessory proteins: leading roles for the supporting cast.
    Trono D
    Cell; 1995 Jul; 82(2):189-92. PubMed ID: 7628010
    [No Abstract]   [Full Text] [Related]  

  • 9. HIV accessory proteins: emerging therapeutic targets.
    Miller RH; Sarver N
    Mol Med; 1995 Jul; 1(5):479-85. PubMed ID: 8529114
    [No Abstract]   [Full Text] [Related]  

  • 10. Could Nef and Vpr proteins contribute to disease progression by promoting depletion of bystander cells and prolonged survival of HIV-infected cells?
    Azad AA
    Biochem Biophys Res Commun; 2000 Jan; 267(3):677-85. PubMed ID: 10673351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of viral regulatory and accessory proteins in HIV-1 replication.
    Seelamgari A; Maddukuri A; Berro R; de la Fuente C; Kehn K; Deng L; Dadgar S; Bottazzi ME; Ghedin E; Pumfery A; Kashanchi F
    Front Biosci; 2004 Sep; 9():2388-413. PubMed ID: 15353294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection.
    Wildum S; Schindler M; Münch J; Kirchhoff F
    J Virol; 2006 Aug; 80(16):8047-59. PubMed ID: 16873261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of HIV-1 gene expression.
    Cullen BR
    FASEB J; 1991 Jul; 5(10):2361-8. PubMed ID: 1712325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superinfection of a defective human immunodeficiency virus type 1 provirus-carrying T cell clone with vif or vpu mutants gives cytopathic virus particles by homologous recombination.
    Kishi M; Tokunaga K; Zheng YH; Bahmani MK; Kakinuma M; Nonoyama M; Lai PK; Ikuta K
    AIDS Res Hum Retroviruses; 1995 Jan; 11(1):45-53. PubMed ID: 7734196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic characterization of vif, vpr, and vpu sequences from long-term survivors of human immunodeficiency virus type 1 infection.
    Zhang L; Huang Y; Yuan H; Tuttleton S; Ho DD
    Virology; 1997 Feb; 228(2):340-9. PubMed ID: 9123841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of prokaryotic cell growth by HIV1 Vpr.
    Bodéus M; Margottin F; Durand H; Rouer E; Benarous R
    Res Virol; 1997; 148(3):207-13. PubMed ID: 9201811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV accessory proteins as therapeutic targets.
    Miller RH; Sarver N
    Nat Med; 1997 Apr; 3(4):389-94. PubMed ID: 9095171
    [No Abstract]   [Full Text] [Related]  

  • 18. Human immunodeficiency virus (HIV)-1 proteins and cytoskeleton: partners in viral life and host cell death.
    Matarrese P; Malorni W
    Cell Death Differ; 2005 Aug; 12 Suppl 1():932-41. PubMed ID: 15818415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HIV-1 Vpu protein: a multifunctional enhancer of viral particle release.
    Bour S; Strebel K
    Microbes Infect; 2003 Sep; 5(11):1029-39. PubMed ID: 12941395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice.
    Aldrovandi GM; Zack JA
    J Virol; 1996 Mar; 70(3):1505-11. PubMed ID: 8627668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.